Hikma Pharmaceuticals Investor Relations Material
Latest events
H2 2024 Q&A
Hikma Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hikma Pharmaceuticals PLC
Access all reports
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company specializing in the development, manufacturing, and distribution of branded, generic, and injectable medicines. The company serves a wide range of therapeutic areas, including cardiovascular, oncology, pain management, and respiratory diseases. Hikma provides high-quality, affordable medications to hospitals, pharmacies, and wholesalers in global markets. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Key slides for Hikma Pharmaceuticals PLC
H2 2024
Hikma Pharmaceuticals PLC
43rd Annual J.P. Morgan Healthcare Conference 2025
Hikma Pharmaceuticals PLC
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
HIK
Country
🇬🇧 United Kingdom